Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2017

14.02.2017 | Original Article

Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review

verfasst von: Jing Wu, Ji Chen, Zhi-Qing Tian, Hao Zhang, Ruo-Lan Gong, Tong-Xin Chen, Li Hong

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Autosomal dominant hyper-IgE syndrome (AD-HIES) is a rare complicated primary immunodeficiency disease (PID). Signal transducer and activator of transcription 3 (STAT3) gene mutation is found to cause AD-HIES. The distribution of AD-HIES patients with STAT3 deficiency in the Chinese population is not clear. Herein, we retrospectively report 17 AD-HIES patients with STAT3 deficiency and demonstrate their clinical, immunological, and genetic features.

Methods

Patients’ clinical data were collected from their medical records. Routine laboratory testing results included lymphocyte subset analysis and immunoglobulin quantification. STAT3 mutations were investigated by sequencing of genomic DNA.

Results

Among 575 patients with PID, 28 (4.87%) were clinically diagnosed as HIES. Among them, 17 (2.96%) were confirmed as STAT3 mutant AD-HIES. The ratio of male to female patients was 8:9. All of the 17 patients had NIH scores over 40 points. The mean ages at onset and diagnosis were 1.05 and 10.35 years, respectively. Three patients (17.65%, 3/17) died with a mean age of 13.33 years. Eczema, recurrent skin infection, and respiratory tract infection were the most common clinical symptoms and are present in all of the 17 patients in this study. Six patients (37.5%, 6/16) suffered complication from BCG vaccination. Noninfection symptoms are characteristic facial features in 17 patients (100%, 17/17), retention of primary teeth in 10 patients (90.91%, 10/11), and abnormal bone fractures in 7 patients (41.18%, 7/17). Eleven types of STAT3 mutations were identified in 17 patients, including 1 novel mutation.

Conclusions

We here retrospectively report the largest Chinese cohort of AD-HIES patients with STAT3 mutation. Unique features, when compared to existing literature reports, include (1) later age of diagnosis, (2) significantly higher rate of BCG complications, and (3) lower rate of candidiasis and chronic otitis media.
Literatur
1.
Zurück zum Zitat Davis SD, Schaller J, Wedgwood RJ. Job’s syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet. 1966;1(7445):1013–5.CrossRefPubMed Davis SD, Schaller J, Wedgwood RJ. Job’s syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet. 1966;1(7445):1013–5.CrossRefPubMed
2.
Zurück zum Zitat Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59–70.PubMed Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59–70.PubMed
4.
Zurück zum Zitat Minegishi Y, Karasuyama H. Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep. 2008;8(5):386–91.CrossRefPubMed Minegishi Y, Karasuyama H. Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep. 2008;8(5):386–91.CrossRefPubMed
11.
Zurück zum Zitat Ives ML, Ma CS, Palendira U, Chan A, Bustamante J, Boisson-Dupuis S, et al. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function. J Allergy Clin Immunol. 2013;132(2):400–11 e9.CrossRefPubMedPubMedCentral Ives ML, Ma CS, Palendira U, Chan A, Bustamante J, Boisson-Dupuis S, et al. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function. J Allergy Clin Immunol. 2013;132(2):400–11 e9.CrossRefPubMedPubMedCentral
17.
20.
Zurück zum Zitat Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007;178(5):2623–9.CrossRefPubMed Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007;178(5):2623–9.CrossRefPubMed
22.
Zurück zum Zitat Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424–32 e8.CrossRefPubMedPubMedCentral Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424–32 e8.CrossRefPubMedPubMedCentral
25.
26.
Zurück zum Zitat Zeng H, Tao Y, Chen X, Zeng P, Wang B, Wei R, et al. Primary immunodeficiency in South China: clinical features and a genetic subanalysis of 138 children. J Investig Allergology Clin Immunol. 2013;23(5):302–8. Zeng H, Tao Y, Chen X, Zeng P, Wang B, Wei R, et al. Primary immunodeficiency in South China: clinical features and a genetic subanalysis of 138 children. J Investig Allergology Clin Immunol. 2013;23(5):302–8.
27.
Zurück zum Zitat Liu JY, Li Q, Chen TT, Guo X, Ge J, Yuan LX. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr. 2011;170(5):661–6. doi:10.1007/s00431-010-1349-6.CrossRefPubMed Liu JY, Li Q, Chen TT, Guo X, Ge J, Yuan LX. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr. 2011;170(5):661–6. doi:10.​1007/​s00431-010-1349-6.CrossRefPubMed
28.
Zurück zum Zitat Zhang LY, Tian W, Shu L, Jiang LP, Zhan YZ, Liu W, et al. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China. Scand J Immunol. 2013;78(3):258–65. doi:10.1111/sji.12063.CrossRefPubMed Zhang LY, Tian W, Shu L, Jiang LP, Zhan YZ, Liu W, et al. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China. Scand J Immunol. 2013;78(3):258–65. doi:10.​1111/​sji.​12063.CrossRefPubMed
29.
Zurück zum Zitat Li ZT, Wang S, Wang X. Mutation analysis of the STAT3 gene in a patient with hyper-IgE syndrome. Chin J Dermatol. 2015;48:735–7. Li ZT, Wang S, Wang X. Mutation analysis of the STAT3 gene in a patient with hyper-IgE syndrome. Chin J Dermatol. 2015;48:735–7.
30.
Zurück zum Zitat Liu JR, Duan XM, Guo AX, Zhao SY, Jiang ZF. A case report of hyper IgE syndrome combined with pulmonary arterial disorders. Chin J Pediatr. 2013;51:692–3. Liu JR, Duan XM, Guo AX, Zhao SY, Jiang ZF. A case report of hyper IgE syndrome combined with pulmonary arterial disorders. Chin J Pediatr. 2013;51:692–3.
31.
Zurück zum Zitat Xue L, Zhang M, Yang Y, Wang S. Mutation analysis of the STAT3 gene in a patient with hyper-IgE syndrome. Chin J Dermatol. 2013;46:716–8. Xue L, Zhang M, Yang Y, Wang S. Mutation analysis of the STAT3 gene in a patient with hyper-IgE syndrome. Chin J Dermatol. 2013;46:716–8.
32.
Zurück zum Zitat Zhang GQ, Cao L, Zhu CM, Wang YJ. STAT3 gene mutation associated with hyper-immunoglobulin E syndrome: a case study and the review of the related literature. Chin J Appl Clin Pediatr. 2016;31:309–11. Zhang GQ, Cao L, Zhu CM, Wang YJ. STAT3 gene mutation associated with hyper-immunoglobulin E syndrome: a case study and the review of the related literature. Chin J Appl Clin Pediatr. 2016;31:309–11.
33.
Zurück zum Zitat Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, et al. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). Immunobiology. 2011;216(8):909–17. doi:10.1016/j.imbio.2011.01.008.CrossRefPubMed Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, et al. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). Immunobiology. 2011;216(8):909–17. doi:10.​1016/​j.​imbio.​2011.​01.​008.CrossRefPubMed
36.
Zurück zum Zitat Lee WI, Huang JL, Jaing TH, Shyur SD, Yang KD, Chien YH, et al. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985–2010. Immunobiology. 2011;216(12):1286–94. doi:10.1016/j.imbio.2011.06.002.CrossRefPubMed Lee WI, Huang JL, Jaing TH, Shyur SD, Yang KD, Chien YH, et al. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985–2010. Immunobiology. 2011;216(12):1286–94. doi:10.​1016/​j.​imbio.​2011.​06.​002.CrossRefPubMed
38.
Zurück zum Zitat Zhong H, Song Z, Wang H, Zhang W, Hao F. A child case of hyper-IgE syndrome. Allergy. 2010;65(12):1622–3.CrossRefPubMed Zhong H, Song Z, Wang H, Zhang W, Hao F. A child case of hyper-IgE syndrome. Allergy. 2010;65(12):1622–3.CrossRefPubMed
39.
Zurück zum Zitat Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122(1):181–7. doi:10.1016/j.jaci.2008.04.037.CrossRefPubMedPubMedCentral Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122(1):181–7. doi:10.​1016/​j.​jaci.​2008.​04.​037.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Jinnestal CL, Belfrage E, Back O, Schmidtchen A, Sonesson A. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol. 2014;53(1):27–33. doi:10.1111/ijd.12198.CrossRefPubMed Jinnestal CL, Belfrage E, Back O, Schmidtchen A, Sonesson A. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol. 2014;53(1):27–33. doi:10.​1111/​ijd.​12198.CrossRefPubMed
43.
Zurück zum Zitat Esposito L, Poletti L, Maspero C, Porro A, Pietrogrande MC, Pavesi P, et al. Hyper-IgE syndrome: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):147–53.CrossRefPubMed Esposito L, Poletti L, Maspero C, Porro A, Pietrogrande MC, Pavesi P, et al. Hyper-IgE syndrome: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):147–53.CrossRefPubMed
44.
Zurück zum Zitat Chandesris MO, Azarine A, Ong KT, et al. Frequent and widespread vascular abnormalities in human STAT3 deficiency. Artery Res. 2011;5(4):163.CrossRef Chandesris MO, Azarine A, Ong KT, et al. Frequent and widespread vascular abnormalities in human STAT3 deficiency. Artery Res. 2011;5(4):163.CrossRef
Metadaten
Titel
Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review
verfasst von
Jing Wu
Ji Chen
Zhi-Qing Tian
Hao Zhang
Ruo-Lan Gong
Tong-Xin Chen
Li Hong
Publikationsdatum
14.02.2017
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2017
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0369-7

Weitere Artikel der Ausgabe 2/2017

Journal of Clinical Immunology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.